Candidate markers for the detection of hepatocellular carcinoma in low-molecular weight fraction of serum.
about
Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data.Automatic selection of preprocessing methods for improving predictions on mass spectrometry protein profilesMS/MS library facilitated MRM quantification of native peptides prepared by denaturing ultrafiltration.Comparison of plasma from healthy nonsmokers, smokers, and lung cancer patients: pattern-based differentiation profiling of low molecular weight proteins and peptides by magnetic bead technology with MALDI-TOF MS.Protein profiling in hepatocellular carcinoma by label-free quantitative proteomics in two west African populationsProteomic profiling of occupational medicamentosa-like dermatitis induced by trichloroethylene in serum based on MALDI-TOF MS.Delineating diseases by IMS-MS profiling of serum N-linked glycans.Biomarkers for Bone Tumours: Discovery from Genomics and Proteomics Studies and Their Challenges.A simple and reliable protocol for mouse serum proteome profiling studies by use of two-dimensional electrophoresis and MALDI TOF/TOF mass spectrometry.Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MSHepatocellular Carcinoma: Tumorigenesis and Prediction Markers.Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.Efficacy and safety of pegylated interferon in children and adolescents infected with chronic hepatitis C: a preliminary study.Relation between sex hormones and hepatocellular carcinoma.
P2860
Q33504781-49E1FF5A-6DE8-4E0A-86FC-E1163C6A4846Q33828155-DF902F80-E17E-4773-9664-D826D6E4DF8FQ34150493-32CCC649-2C04-4F05-ADCA-7C8BB6AEC658Q34166788-5C27D0A1-7C17-4903-82B8-0F853E777312Q34918154-FA91A987-52D0-452B-9D66-A8C954B5F5AEQ35491175-0868A052-73FA-49AA-909F-7F88F807C51FQ35913954-A5144B03-E76C-4D50-B51D-B3B4669C31BEQ36758011-FBA209C7-47F0-43E1-8EFE-59216EF71A4FQ36926647-F53CDED8-2A80-411B-AE94-4B93BCF98616Q37055406-111C7CDA-86A0-4B6B-AEA0-6573FCE69DCDQ37477526-2B54606D-9770-482A-A5B2-F6BB91A1D8A3Q37484011-D189FF32-5FB1-411E-9DC5-4241362EC9DFQ38854176-3E50F273-ABF4-462B-BB8F-0F81654A554AQ38985066-1A00F0B6-B5FE-4C23-A938-05D1FC01C038
P2860
Candidate markers for the detection of hepatocellular carcinoma in low-molecular weight fraction of serum.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Candidate markers for the dete ...... ular weight fraction of serum.
@ast
Candidate markers for the dete ...... ular weight fraction of serum.
@en
Candidate markers for the dete ...... ular weight fraction of serum.
@nl
type
label
Candidate markers for the dete ...... ular weight fraction of serum.
@ast
Candidate markers for the dete ...... ular weight fraction of serum.
@en
Candidate markers for the dete ...... ular weight fraction of serum.
@nl
prefLabel
Candidate markers for the dete ...... ular weight fraction of serum.
@ast
Candidate markers for the dete ...... ular weight fraction of serum.
@en
Candidate markers for the dete ...... ular weight fraction of serum.
@nl
P2093
P2860
P356
P1433
P1476
Candidate markers for the dete ...... ular weight fraction of serum.
@en
P2093
Antai Wang
Christopher A Loffredo
Francoise Seillier Moiseiwitsch
Habtom W Ressom
Iman Gouda
Lenka Goldman
Mohamed Abdel-Hamid
Radoslav Goldman
Rency S Varghese
Sohair A Eissa
P2860
P304
P356
10.1093/CARCIN/BGM177
P407
P577
2007-08-27T00:00:00Z